Cherry Brian N
- SEC CIK
- 0001290922
In the past year, 1 open-market purchase filing worth $1.00M and no sales.
Current role at each company
- ATRA Atara Biotherapeutics, Inc.Directoras of Sep 4, 2026
- ZYME Zymeworks Inc.Directoras of Jan 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cherry Brian N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATRA Atara Biotherapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 (view filing)6:20 PM ET | Sep 4 | Same day | Cherry Brian NDirector | PPurchase | +104.2K | $9.60 | +$1.00M | +167.1%166.5K after |